Rowley JD - Search Results

1

Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo.

Samuels BL, Larson RA, Le Beau MM, Daly KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Golomb HM. Samuels BL, et al. Among authors: rowley jd. Leukemia. 1988 Feb;2(2):79-83. Leukemia. 1988. PMID: 3343866

2

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.

Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA. Neuman WL, et al. Among authors: rowley jd. Blood. 1992 Mar 15;79(6):1501-10. Blood. 1992. PMID: 1347709 Free article.

3

Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.

Olopade OI, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR, Le Beau MM, Vardiman JW, Rowley JD. Olopade OI, et al. Among authors: rowley jd. Blood. 1992 Dec 1;80(11):2873-82. Blood. 1992. PMID: 1450412 Free article.

4

The proportion of abnormal karyotypes in acute leukemia samples related to method of preparation.

Li YS, Le Beau MM, Mick R, Rowley JD. Li YS, et al. Among authors: rowley jd. Cancer Genet Cytogenet. 1991 Mar;52(1):93-100. doi: 10.1016/0165-4608(91)90058-3. Cancer Genet Cytogenet. 1991. PMID: 2009515

5

t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman JW, Rowley JD, Le Beau MM. Rubin CM, et al. Among authors: rowley jd. Blood. 1990 Dec 15;76(12):2594-8. Blood. 1990. PMID: 2265251 Free article.

6

Deletions of interferon genes in acute lymphoblastic leukemia.

Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM, Rowley JD. Diaz MO, et al. Among authors: rowley jd. N Engl J Med. 1990 Jan 11;322(2):77-82. doi: 10.1056/NEJM199001113220202. N Engl J Med. 1990. PMID: 2294436 Free article.

7

Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia.

Schwartz JL, Karrison T, Le Beau MM, Larson RA, Sagher D, Strauss B, Rowley JD, Weichselbaum RR. Schwartz JL, et al. Among authors: rowley jd. Mutat Res. 1989 Apr;216(2):119-26. doi: 10.1016/0165-1161(89)90012-5. Mutat Res. 1989. PMID: 2494444

8

Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.

Raimondi SC, Dubé ID, Valentine MB, Mirro J Jr, Watt HJ, Larson RA, Bitter MA, Le Beau MM, Rowley JD. Raimondi SC, et al. Among authors: rowley jd. Leukemia. 1989 Jan;3(1):42-7. Leukemia. 1989. PMID: 2642576 Review.

9

Cytogenetic and molecular analysis of therapy-related leukemia.

Rowley JD, Le Beau MM. Rowley JD, et al. Ann N Y Acad Sci. 1989;567:130-40. doi: 10.1111/j.1749-6632.1989.tb16465.x. Ann N Y Acad Sci. 1989. PMID: 2679313 Review. No abstract available.

10

Der(5)t(5;7)(q11.2;p11.2): a new recurring abnormality in malignant myeloid disorders.

Thangavelu M, Bitter MA, Larson RA, Davis EM, Rowley JD, Le Beau MM. Thangavelu M, et al. Among authors: rowley jd. Cancer Genet Cytogenet. 1989 Jan;37(1):1-8. doi: 10.1016/0165-4608(89)90067-8. Cancer Genet Cytogenet. 1989. PMID: 2917326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters